Insider filing · MLTX
Catherine Moukheibir
Director
profile →
MoonLake Immunotherapeutics
MLTX · Healthcare · 18 filings in 24 months
ticker →
Catherine Moukheibir sold $1.1M of MoonLake Immunotherapeutics (MLTX)
Executed Jul 3 2025, disclosed Jul 7 2025, 4 days later.
Value, as filed
$1.1M
23,500 sh × $48.79
Executed
Jul 3 2025
the trade date, as filed
Disclosed
Jul 7 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CMCatherine Moukheibir (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $1.1M of MLTX (23,500 sh × $48.79, as filed), executed Jul 3 2025.
The name
MLTXHealthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→